Form 10-Q EchoStar CORP For: Jun 30
http://archive.fast-edgar.com/20140807/A5AZN62C8Z22HZZZ27JA2ZZZMTPQZ2Q2ZV62
Filed on: August 7, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Genentech Announces Positive Phase II Results for Dual GLP-1/GIP Receptor Agonist Enicepatide in People Living With Type 2 Diabetes and Overweight or Obesity
- The Law Offices of Eric A. Rudolph Proudly Sponsors Boo2Bullying's 4th Annual "Kick Bullying to the Curb" Event in Palm Springs
- [Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase II results for dual GLP-1/GIP receptor agonist enicepatide in people living with type 2 diabetes and overweight or obesity
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share